EMSF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 24 of 26 cases where EMSF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where EMSF's RSI Indicator exited the oversold zone, 12 of 14 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 27 of 34 cases where EMSF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for EMSF just turned positive on November 11, 2026. Looking at past instances where EMSF's MACD turned positive, the stock continued to rise in 26 of 31 cases over the following month. The odds of a continued upward trend are 84%.
Following a +5.15% 3-day Advance, the price is estimated to grow further. Considering data from situations where EMSF advanced for three days, in 165 of 201 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Momentum Indicator moved below the 0 level on October 07, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EMSF as a result. In 47 of 56 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
EMSF moved below its 50-day moving average on October 12, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for EMSF crossed bearishly below the 50-day moving average on October 15, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 73%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMSF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for EMSF entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Aroon Indicator for GGAL entered a downward trend on November 10, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 218 similar instances where the Aroon Indicator formed such a pattern. In 182 of the 218 cases the stock moved lower. This puts the odds of a downward move at 83%.
The Momentum Indicator moved below the 0 level on October 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GGAL as a result. In 71 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The Moving Average Convergence Divergence Histogram (MACD) for GGAL turned negative on October 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 38 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GGAL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.93% 3-day Advance, the price is estimated to grow further. Considering data from situations where GGAL advanced for three days, in 256 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
GGAL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 2 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock better than average.
The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: GGAL's P/B Ratio (0.001) is slightly lower than the industry average of (1.262). P/E Ratio (0.055) is within average values for comparable stocks, (13.479). Projected Growth (PEG Ratio) (0.220) is also within normal values, averaging (1.190). Dividend Yield (0.007) settles around the average of (0.035) among similar stocks. GGAL's P/S Ratio (1.188) is slightly lower than the industry average of (3.738).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. GGAL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
GGAL | ||
|---|---|---|
OUTLOOK RATING 1..100 | 55 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 16 Undervalued | |
PROFIT vs RISK RATING 1..100 | 2 | |
SMR RATING 1..100 | 1 | |
PRICE GROWTH RATING 1..100 | 80 | |
P/E GROWTH RATING 1..100 | 97 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| EMSF | GGAL | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 86% | 1 day ago 79% |
| Stochastic ODDS (%) | 1 day ago 79% | 1 day ago 74% |
| Momentum ODDS (%) | 6 days ago 84% | 1 day ago 82% |
| MACD ODDS (%) | 1 day ago 84% | 1 day ago 81% |
| TrendWeek ODDS (%) | 1 day ago 81% | 1 day ago 76% |
| TrendMonth ODDS (%) | 1 day ago 74% | 1 day ago 81% |
| Advances ODDS (%) | 3 days ago 82% | 22 days ago 81% |
| Declines ODDS (%) | 10 days ago 84% | 1 day ago 78% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 71% |
| Aroon ODDS (%) | 1 day ago 63% | 1 day ago 83% |
A.I.dvisor tells us that EMSF and ZH have been poorly correlated (+15% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EMSF and ZH's prices will move in lockstep.
| Ticker / NAME | Correlation To EMSF | 1D Price Change % | ||
|---|---|---|---|---|
| EMSF | 100% | +2.84% | ||
| ZH - EMSF | 15% Poorly correlated | +2.64% | ||
| LEGN - EMSF | 6% Poorly correlated | -4.26% | ||
| NU - EMSF | 4% Poorly correlated | +1.99% | ||
| TSM - EMSF | 4% Poorly correlated | +4.25% | ||
| GGAL - EMSF | -4% Poorly correlated | -0.13% | ||
More | ||||
A.I.dvisor indicates that over the last year, GGAL has been closely correlated with BMA. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if GGAL jumps, then BMA could also see price increases.
| Ticker / NAME | Correlation To GGAL | 1D Price Change % | ||
|---|---|---|---|---|
| GGAL | 100% | -0.13% | ||
| BMA - GGAL | 94% Closely correlated | -1.04% | ||
| BBAR - GGAL | 92% Closely correlated | -0.74% | ||
| SUPV - GGAL | 92% Closely correlated | +1.75% | ||
| AVAL - GGAL | 49% Loosely correlated | -5.39% | ||
| INTR - GGAL | 45% Loosely correlated | +1.77% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| QGRW | 64.78 | 0.89 | +1.39% |
| WisdomTree U.S. Quality Growth Fund (QGRW) | |||
| XPH | 68.82 | 0.89 | +1.31% |
| State Street SPDR S&P Pharmaceuticals ETF (XPH) | |||
| DBE | 35.11 | 0.12 | +0.34% |
| Invesco DB Energy Fund (DBE) | |||
| TINS | 28.04 | N/A | N/A |
| Templeton International Insights ETF (TINS) | |||
| FBDC | 17.01 | -0.06 | -0.35% |
| FT Confluence BDC & Specialty Finance Income ETF (FBDC) | |||